跳至主要内容
临床试验/NL-OMON29635
NL-OMON29635已完成不适用

Development of humoral and cellular immune response in infants after pneumococcal conjugate vaccinations with Synflorix® or Prevenar-13®.

ational Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control (CIb)0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. The children have to be of normal health (same health criteria apply as used in well-baby clinics when a child receives a vaccination, e.g. also children with small increases in temperature (<38.5C) or cold are seen as children with normal health);
  • 2. The parents/legally representatives have to be willing and able to allow their child to participate in the trial according to the described procedures;

排除标准

  • 1. PCV13 group: Previous vaccinations with PCV7 or PCV10;
  • 2. PCV10 group: Previous vaccinations with PCV7 or PCV13;

研究者

发起方
ational Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control (CIb)

相似试验